Allarity Therapeutics Inc...
(ALLR)
undefined
undefined%
At close: undefined
1.02
-0.49%
After-hours Dec 13, 2024, 07:56 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | 120.00K |
Cost of Revenue | 37.00K | 120.00K | 106.00K | 86.00K | - |
Gross Profit | -37.00K | -120.00K | -106.00K | -86.00K | 120.00K |
Operating Income | -17.93M | -34.46M | -26.56M | -9.23M | -17.61M |
Interest Income | 22.00K | 30.00K | - | - | 7.00K |
Pretax Income | -12.62M | -17.58M | -26.52M | -7.23M | -18.98M |
Net Income | -11.90M | -16.06M | -26.65M | -5.07M | -14.40M |
Selling & General & Admin | 10.03M | 9.96M | 12.36M | 4.10M | 3.87M |
Research & Development | 7.87M | 6.93M | 14.20M | 5.13M | 6.37M |
Other Expenses | - | - | -474.00K | -681.00K | - |
Operating Expenses | 17.89M | 16.89M | 26.56M | 9.23M | 10.24M |
Interest Expense | 498.00K | 223.00K | 499.00K | 227.00K | 3.31M |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 17.93M | 16.89M | 26.56M | 9.23M | 10.24M |
Income Tax | -717.00K | -1.52M | 133.00K | -2.16M | -4.58M |
Shares Outstanding (Basic) | 1.99B | 11.34 | 7.57 | 3.89 | 3.89 |
Shares Outstanding (Diluted) | 1.99B | 11.34 | 7.57 | 3.89 | 3.89 |
EPS (Basic) | -0.01 | -1.86M | -3.52M | -1.70M | -189.61K |
EPS (Diluted) | -0.01 | -1.86M | -3.52M | -1.70M | -189.61K |
EBITDA | -12.08M | -17.24M | -25.91M | -6.01M | -15.58M |
Depreciation & Amortization | 37.00K | 120.00K | 106.00K | 86.00K | 85.00K |